18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)-Reference-Cited by-同舟云学术

18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

Published:2017-11-22 Issue:11 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Martínez Gabriel¹²³,Vernooij Robin WM¹,Fuentes Padilla Paulina¹²,Zamora Javier⁴,Flicker Leon⁵,Bonfill Cosp Xavier⁶⁷

Affiliation:

1. Iberoamerican Cochrane Centre; C/ Sant Antoni Maria Claret 167 Pavelló 18 Planta 0 Barcelona Barcelona Spain 08025

2. Universidad de Antofagasta; Faculty of Medicine and Dentistry; Antofagasta Chile

3. Institut Català de Neurociències Aplicades; Alzheimer Research Center and Memory Clinic of Fundació ACE; Barcelona Spain

4. Ramon y Cajal Institute for Health Research (IRYCIS), CIBER Epidemiology and Public Health (CIBERESP), Madrid (Spain) and Women's Health Research Unit, Centre for Primary Care and Public Health, Queen Mary University of London; Clinical Biostatistics Unit; London Madrid UK

5. University of Western Australia; Western Australian Centre for Health & Ageing - WACHA; Crawley Perth Western Australia Australia 6014

6. CIBER Epidemiología y Salud Pública (CIBERESP); Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret 167 Pavilion 18 Barcelona Catalunya Spain 08025

7. Universitat Autònoma de Barcelona; Sant Antoni Maria Claret, 167 Pavilion 18 (D-13) Barcelona Catalunya Spain 08025

Publisher

Wiley

Subject

Pharmacology (medical)

Reference104 articles.

1. Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests;Bahar-Fuchs;Journal of Alzheimer's Disease,2013

2. Conversion from mild cognitive impairment to Alzheimer's disease over 12 months: predictive value of AB imaging with 18F-Florbetaben;Ong;Internal Medicine Journal,2011

3. Conversion from mild cognitive impairment to Alzheimer's disease over 12 months: predictive value of AB imaging with 18F-florbetaben;Ong;Alzheimer's & Dementia,2011

4. Cognitive change and Ab deposition in MCI subjects studied with serial 18F-florbetaben PET over 2 years;Ong;Alzheimer's & Dementia,2012

5. A two-year longitudinal assessment of abeta deposition in MCI with 18f-florbetaben;Ong;Internal Medicine Journal,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scottish Intercollegiate Guidelines Network Guidance on Dementia: The Investigation of Suspected Dementia (SIGN 168) with Focus on Biomarkers—Executive Summary;Thrombosis and Haemostasis;2024-05-24

2. Effects of workbook training using editorials and newspaper articles in adults with preclinical stage of dementia;Scientific Reports;2024-01-27

3. Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History;Journal of Clinical Medicine;2024-01-17

4. Strategies for translating proteomics discoveries into drug discovery for dementia;Neural Regeneration Research;2024-01

5. Praktischer Leitfaden für die klinische Anwendung;PET/CT-Atlas;2024